The NUZ-001 arm of the HEALEY ALS trial is expanding enrollment to 240 participants. NUZ-001 is an experimental ALS therapy ...

The new initiative will be led by the Allen Institute, a nonprofit medical research organization, through its Brain Health Accelerator — a research initiative to study neurodegenerative diseases. The ...

Lou Gehrig Day on June 2 raises ALS awareness and funds for research. MLB and advocacy groups will host events to honor Gehrig's legacy and support patients. ALS is a neurodegenerative disease causing ...

Living near a moderate amount of green space may lower ALS risk. Very low greenness and very high greenness may increase risk, for different reasons. The study could have implications for public ...

French actor Pierre Deny died from a sudden and severe case of ALS. Deny is best known internationally for his role on Netflix's "Emily in Paris." The disease typically progresses quickly, leading to ...

At the time, Todd didn’t need to use the PEG tube for nutrition because he was still eating by mouth, and almost seven years later, he’s still eating his meals by mouth. We did, however, begin using ...

The longer I live with ALS, the more I’m forced to learn about myself by constantly adjusting to my body’s limitations and learning how to pace my days. Lately, I’ve been taking lessons in how to ...

People who had a history of a traumatic head injury were nearly 50% more likely than those without head injury to have an ALS diagnosis, researchers found. However, multiple head ...

AC Immune’s experimental imaging agent ACI-19626 continues to show a good safety profile and has shown promise for detecting toxic TDP-43 protein clumps in people with amyotrophic lateral sclerosis ...

It is important to note that many of these technologies are still in early stages of development or clinical testing – they are not yet standard treatments, and what works for one person may not work ...

Juliet lost her husband, Jeff, to ALS in 2020, 19 months after his diagnosis. Together Jeff and Juliet enjoyed being on the water, live music, pets, and traveling. She was his primary caregiver, and ...

PAS-004, an experimental drug for ALS, received FDA orphan drug designation to accelerate its development. The therapy targets inflammation and TDP-43 protein clumps, hallmarks of ALS progression. A ...